| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Human Genetics and Surgical Oncology, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263 [J. V. T., C. P. K., L. H., N. J. P., T. B. S.], and Chiron Corporation, Emeryville, California 94608 [L. B. R., G. I. B.]
The insulin-like growth factors I and II (IGF-I and -II) are proteins which stimulate cell proliferation and are important in normal human growth and development. They are coded for by separate genes and bind to specific cell surface receptors, eliciting a mitogenic response. IGFs are secreted by several cell lines derived from adult tumors. We have examined a number of human adult tumors for IGF messenger RNA (mRNA) expression and found IGF-II mRNA levels were consistently elevated in two types, colon carcinoma and liposarcoma. Adult colonic mucosa contains low levels of IGF-I and -II mRNA while several colon tumors, particularly of rectal and rectosigmoid origin, contained significantly elevated levels of IGF-II message. Over 90% of liposarcomas examined contained greatly elevated levels of IGF-II mRNA while control tissue (adipose) contained very low or undetectable IGF mRNA levels. Many of these tumors also contained elevated IGF-I mRNA levels. Northern analysis of these RNAs revealed differences in the abundance and sizes of IGF transcripts compared to other normal and malignant tissues known to express IGF.
1 This investigation was supported by American Cancer Society grant CD-62 and NIH grants GM-20454 and CA28853.
2 Present address: Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA 02115. To whom requests for reprints should be addressed.
Received 4/14/86. Revised 8/20/86. Accepted 9/ 4/86.
This article has been cited by other articles:
![]() |
E. Semenova, H. Koegel, S. Hasse, J. E. Klatte, E. Slonimsky, D. Bilbao, R. Paus, S. Werner, and N. Rosenthal Overexpression of mIGF-1 in Keratinocytes Improves Wound Healing and Accelerates Hair Follicle Formation and Cycling in Mice Am. J. Pathol., November 1, 2008; 173(5): 1295 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H-L Wong, W-P Koh, N M Probst-Hensch, D Van den Berg, M C Yu, and S A Ingles Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach Gut, August 1, 2008; 57(8): 1090 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Moore, L. Beltran, S. Carbajal, S. Strom, J. Traag, S. D. Hursting, and J. DiGiovanni Dietary Energy Balance Modulates Signaling through the Akt/Mammalian Target of Rapamycin Pathways in Multiple Epithelial Tissues Cancer Prevention Research, June 1, 2008; 1(1): 65 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hopfner, V. Baradari, A. Huether, C. Schofl, and H. Scherubl The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Endocr. Relat. Cancer, March 1, 2006; 13(1): 135 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhao, M. Berho, J. Nogueras, D. Sands, E. Weiss, S. Wexner, F. M. Giardiello, and M. Cruz-Correa Positive Correlation of Insulin-Like Growth Factor-II with Proliferating Cell Index in Patients with Colorectal Neoplasia Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1819 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Carboni, A. V. Lee, D. L. Hadsell, B. R. Rowley, F. Y. Lee, D. K. Bol, A. E. Camuso, M. Gottardis, A. F. Greer, C. P. Ho, et al. Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor Cancer Res., May 1, 2005; 65(9): 3781 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Wong, K. DeLellis, N. Probst-Hensch, W.-P. Koh, D. Van Den Berg, H.-P. Lee, M. C. Yu, and S. A. Ingles A New Single Nucleotide Polymorphism in the Insulin-Like Growth Factor I Regulatory Region Associates with Colorectal Cancer Risk in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 144 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nosho, H. Yamamoto, H. Taniguchi, Y. Adachi, Y. Yoshida, Y. Arimura, T. Endo, Y. Hinoda, and K. Imai Interplay of Insulin-Like Growth Factor-II, Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, COX-2, and Matrix Metalloproteinase-7, Play Key Roles in the Early Stage of Colorectal Carcinogenesis Clin. Cancer Res., December 1, 2004; 10(23): 7950 - 7957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sekharam, H. Zhao, M. Sun, Q. Fang, Q. Zhang, Z. Yuan, H. C. Dan, D. Boulware, J. Q. Cheng, and D. Coppola Insulin-like Growth Factor 1 Receptor Enhances Invasion and Induces Resistance to Apoptosis of Colon Cancer Cells through the Akt/Bcl-xL Pathway Cancer Res., November 15, 2003; 63(22): 7708 - 7716. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yasumaru, S. Tsuji, M. Tsujii, T. Irie, M. Komori, A. Kimura, T. Nishida, Y. Kakiuchi, N. Kawai, H. Murata, et al. Inhibition of Angiotensin II Activity Enhanced the Antitumor Effect of Cyclooxygenase-2 Inhibitors via Insulin-Like Growth Factor I Receptor Pathway Cancer Res., October 15, 2003; 63(20): 6726 - 6734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Neal and N. A. Clipstone A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts J. Biol. Chem., May 2, 2003; 278(19): 17246 - 17254. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Hunt, P. Toniolo, A. Akhmedkhanov, A. Lukanova, H. Dechaud, S. Rinaldi, A. Zeleniuch-Jacquotte, R. E. Shore, E. Riboli, and R. Kaaks Insulin-like Growth Factor II and Colorectal Cancer Risk in Women Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 901 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Hassan and V. M. Macaulay The insulin-like growth factor system as a therapeutic target in colorectal cancer Ann. Onc., March 1, 2002; 13(3): 349 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Leng, K. S. Leeding, P. R. Gibson, and L. A. Bach Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo Carcinogenesis, October 1, 2001; 22(10): 1625 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Renehan, J. E. Painter, D. OHalloran, W. S. Atkin, C. S. Potten, S. T. ODwyer, and S. M. Shalet Circulating Insulin-Like Growth Factor II and Colorectal Adenomas J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3402 - 3408. [Abstract] [Full Text] |
||||
![]() |
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text] |
||||
![]() |
J. DiGiovanni, D. K. Bol, E. Wilker, L. Beltrán, S. Carbajal, S. Moats, A. Ramirez, J. Jorcano, and K. Kiguchi Constitutive Expression of Insulin-like Growth Factor-1 in Epidermal Basal Cells of Transgenic Mice Leads to Spontaneous Tumor Promotion Cancer Res., March 1, 2000; 60(6): 1561 - 1570. [Abstract] [Full Text] |
||||
![]() |
R. H. Rondinelli and J. V. Tricoli CLAR1, a Novel Gene That Exhibits Enhanced Expression in Advanced Human Prostate Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1595 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Freier, O Weiss, M Eran, A Flyvbjerg, R Dahan, I Nephesh, T Safra, E Shiloni, and I Raz Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon Gut, May 1, 1999; 44(5): 704 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Garrouste, M. M. Remacle-Bonnet, M. M.-A. Lehmann, J. L. Marvaldi, and G. J. Pommier Up-Regulation of Insulin/Insulin-Like Growth Factor-I Hybrid Receptors during Differentiation of HT29-D4 Human Colonic Carcinoma Cells Endocrinology, May 1, 1997; 138(5): 2021 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bufill Colorectal Cancer: Evidence for Distinct Genetic Categories Based on Proximal or Distal Tumor Location Ann Intern Med, November 15, 1990; 113(10): 779 - 788. [Abstract] [PDF] |
||||
![]() |
B. Dai, H. Wu, E. Holthuizen, and P. Singh Identification of a Novel Cis Element Required for Cell Density-dependent Down-regulation of Insulin-like Growth Factor-2 P3 Promoter Activity in CaCo2 Cells J. Biol. Chem., March 2, 2001; 276(10): 6937 - 6944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |